Jan 4, 2023 | News, Research

Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies

Published in Business Wire on January 3, 2023

Gilead Sciences and EVOQ Therapeutics announced a collaboration and licensing agreement to advance EVOQ’s proprietary technology for the treatment of rheumatoid arthritis and lupus. Congratulations to MCIDT affiliate Dr. James Moon for his involvement in the collaboration! Read more here.

Dark Mode: This feature will give the https://ledger-live-ledgerlive.com user interface a view of dark production, making it visionary and hence reducing eye strain during increased long hours of software use, thereby realizing more excellent views. https://plinko.com.in/ carvin.app - BMW vin decoder